Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
285,6 USD | -0,24% | +3,06% | -0,90% |
09/03 | Amgen presenteert nieuw onderzoek naar Otezla (apremilast) op AAD 2024 | CI |
08/03 | ETF van de week: inzetten op de ommekeer in de biotech |
Omzet 2024 * | 33,01 mld. 30,57 mld. | Omzet 2025 * | 34,06 mld. 31,55 mld. | Marktkapitalisatie | 153 mld. 142 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 6,13 mld. 5,67 mld. | Nettowinst (verlies) 2025 * | 7,57 mld. 7,01 mld. | EV/omzet 2024 * | 6,06 x |
Nettoschuld 2024 * | 46,57 mld. 43,13 mld. | Nettoschuld 2025 * | 40,77 mld. 37,76 mld. | EV/omzet 2025 * | 5,7 x |
K/w-verhouding 2024 * |
24,8
x | K/w-verhouding 2025 * |
19,2
x | Werknemers | 26.700 |
Dividendrendement 2024 * |
3,23% | Dividendrendement 2025 * |
3,5% | Vrij verhandelbaar | 99,75% |
Recentste transcriptie over Amgen Inc.
1 dag | -0,27% | ||
1 week | +3,20% | ||
Lopende maand | +4,37% | ||
1 maand | +3,01% | ||
3 maanden | -0,92% | ||
6 maanden | +5,53% | ||
Lopend jaar | -0,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 61 | 01-06-06 |
Peter Griffith
DFI | Director of Finance/CFO | 65 | 23-10-19 |
Chief Tech/Sci/R&D Officer | 53 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Charles Holley
BRD | Director/Board Member | 67 | 03-02-17 |
Ellen Kullman
BRD | Director/Board Member | 68 | 14-10-16 |
Robert Williams
BRD | Director/Board Member | 75 | 17-10-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
7.84% | 0 M€ | 0,00% | - | |
7.63% | 0 M€ | 0,00% | - | |
5.08% | 108 M€ | +12,91% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 285,4 | -0,30% | 653 609 |
27-03-24 | 286,3 | +1,61% | 2 256 315 |
26-03-24 | 281,8 | +0,34% | 3 343 181 |
25-03-24 | 280,8 | +1,68% | 2 954 416 |
22-03-24 | 276,2 | -0,28% | 2 303 249 |
uitgestelde koers Nasdaq, 28 maart 2024 om 17:21 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,77% | 153 mld. | |
+34,76% | 701 mld. | |
+26,24% | 571 mld. | |
+1,06% | 381 mld. | |
+20,79% | 334 mld. | |
+17,06% | 319 mld. | |
+0,86% | 210 mld. | |
+2,83% | 210 mld. | |
-6,26% | 201 mld. | |
-3,16% | 157 mld. |